Skip to main content
. Author manuscript; available in PMC: 2017 Jan 26.
Published in final edited form as: Curr Trends Immunol. 2016;17:117–123.

Fig. 4.

Fig. 4

Dose response to hemin treatment of EBOV-infected HeLa and HFF1 cells. HeLa cells (panel A) and HFF1 cells (panel B) were infected with Kikwit-95 Zaire strain of Ebola virus under BSL-4 conditions for 48 hours in the presence of the indicated concentrations of hemin. It gave activity with EC50 = 17–27 µM in HeLa cells and CC50 > 100 µM and EC50 = 26–30 µM in HFF1 and CC50 > 100 µM, n = 4 done in two independent experiments. Cellular viability of the infected cells at various hemin concentrations are illustrated in panels C and D.